Cargando…
microRNA-155 inhibition restores Fibroblast Growth Factor 7 expression in diabetic skin and decreases wound inflammation
Treatment for chronic diabetic foot ulcers is limited by the inability to simultaneously address the excessive inflammation and impaired re-epithelization and remodeling. Impaired re-epithelization leads to significantly delayed wound closure and excessive inflammation causes tissue destruction, bot...
Autores principales: | Moura, João, Sørensen, Anja, Leal, Ermelindo C., Svendsen, Rikke, Carvalho, Lina, Willemoes, Rie Juul, Jørgensen, Per Trolle, Jenssen, Håvard, Wengel, Jesper, Dalgaard, Louise Torp, Carvalho, Eugénia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456606/ https://www.ncbi.nlm.nih.gov/pubmed/30967591 http://dx.doi.org/10.1038/s41598-019-42309-4 |
Ejemplares similares
-
Mechanistic Actions of microRNAs in Diabetic Wound Healing
por: Petkovic, Marija, et al.
Publicado: (2020) -
Improved diabetic wound healing by LFcinB is associated with relevant changes in the skin immune response and microbiota
por: Mouritzen, Michelle V., et al.
Publicado: (2021) -
Heme Oxygenase-1 as Therapeutic Target for Diabetic Foot Ulcers
por: Leal, Ermelindo Carreira, et al.
Publicado: (2022) -
Bioactive Antimicrobial Peptides as Therapeutic Agents for Infected Diabetic Foot Ulcers
por: Da Silva, Jessica, et al.
Publicado: (2021) -
Green Antimicrobials as Therapeutic Agents for Diabetic Foot Ulcers
por: Teixeira, Ines D., et al.
Publicado: (2023)